📢 Our June Issue is live! 🎉 Introducing our Migration Series:
7 papers with 7 key areas crucial for Europe to transition from migrant health inequality to migrant health equity.
👇
thelancet.com/journals/lanep…
Series Hub: tinyurl.com/3pej8ypr

News: Kenya sounds alarm over counterfeit #cancerdrugs thelancet.com/journals/lanon…

Also in the May issue:

Results from ENZA-p:

177Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant #prostatecancer : an open-label, multicentre, randomised, phase 2 trial thelancet.com/journals/lanon…

I’m hosting a webinar on abstract writing for the Conference on Liver Disease in Africa 2024 on Thursday; registration open at virology.eventsair.com/solda/webinar-…

#LiverTwitter #SOLDA Solda - Society on Liver Disease in Africa

In our May issue:

Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study thelancet.com/journals/lanon…

📢 We are pleased to announce the launch of our Series: '𝗔𝗱𝗱𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝗺𝗶𝗴𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝗲𝗾𝘂𝗶𝘁𝘆 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲' on May 28th in 𝗚𝗲𝗻𝗲𝘃𝗮. Join us if you can.
Register here: tinyurl.com/2pt5s8f2

News: Medical #debt of people with #cancer in the #USA thelancet.com/journals/lanon…

In our May issue - ICYMI:

Changes in hospital mortality in patients with #cancer during the #COVID19 pandemic in the #UK (ISARIC-CCP-UK): a prospective, multicentre cohort study thelancet.com/journals/lanon…

Ductal carcinoma in situ (DCIS) accounts for 15–25% of all breast cancer diagnoses.

A review summarises the key knowledge available regarding the natural history of DCIS, prognostic markers, and treatment results to inform balanced management strategies: hubs.li/Q02xc20v0

New research - Ruco et al - Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort study

thelancet.com/journals/langa…

#GITwitter #CRCSM #ColorectalCancer Nancy Baxter MD PhD Arlinda R.

ICYMI:

Results from the multicentre, single-arm, phase 2 TRAIN-3 study: MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive #breastcancer thelancet.com/journals/lanon…

The global fight for better health outcomes & decades of progress in treating infections are at risk due to antimicrobial resistance ( #AMR ).

Ahead of a UN high-level meeting on the issue, The Lancet is launching a new 4-paper Series 📄

Register ⬇️
hubs.li/Q02wVtx60

Editor-in-Chief Rob Brierley will be at the 1st African Viral Hepatitis Convention, co-convened with #IHPBA24 in Cape Town, this week; details below if you wish to get in touch

Learn about our scope & impact here: hubs.li/Q01CYmHX0

#IHPBA2024 #AVHC #LiverTwitter #NoHep

Our 24th volume is OUT, specially focused on #cancer ! We have Editorial: ' #Research in cancer needs pivotal changes'. Research studies on cancer from #India , #Bhutan ; preventing cancer in #Asia & much more...

Read the volume
👉bit.ly/3JYNX2v

Online First:
Effect of #ProjectOrbis participation by the Swiss regulator Swissmedic on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis
#cancerdrugs
thelancet.com/journals/lanon…

Also Online First:

#Overallsurvival benefits of #cancerdrugs initially approved by the US Food and Drug Administration U.S. FDA on the basis of immature survival data: a retrospective analysis
thelancet.com/journals/lanon…

Out in The Lancet Oncology, the latest analysis by our colleague Dr Anita Wolfer head of the breast cancer clinic HUG and colleagues at Swissmedic - Project Orbis a collaborative parallel-review programme launched by U.S. FDA in 2019 to expedite patient access to cancer drugs.

Online First:

Results from KEYNOTE-057:
#Pembrolizumab monotherapy for high-risk non-muscle-invasive #bladdercancer without carcinoma in situ and unresponsive to BCG: a single-arm, multicentre, phase 2 trial
#gusm
thelancet.com/journals/lanon…

News: #Cancer on the agenda during IAEA - International Atomic Energy Agency ⚛️ Director General's visit to #Chile thelancet.com/journals/lanon…

News: Protests in #SouthAfrica over unused #cancer -treatment fund thelancet.com/journals/lanon…